MedPath

Minimal Invasive Imaging of Coronary Artery Disease in Patients With Asymptomatic Myocardial Injury After Major Non-cardiac Surgery.

Not Applicable
Conditions
Myocardium; Injury
Coronary Artery Disease
Interventions
Other: Minimal invasive cardiac imaging
Registration Number
NCT01960309
Lead Sponsor
UMC Utrecht
Brief Summary

This is a cross-sectional pilot study to assess coronary artery disease with minimal invasive techniques in patients with asymptomatic troponin elevation after noncardiac surgery. The primary objective is to quantify coronary artery disease, as determined by coronary CT and MR, as a cause of postoperative myocardial injury. The secondary objective is to correlate coronary calciumscore to postoperative levels of troponin.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Major noncardiac surgery with a planned minimal postoperative hospital stay of 2 days
  • Age > 59 years
  • Troponin_I elevation > 0.06 ng/ml in the first 3 post-operative days
  • No clinical symptoms of myocardial ischemia
Exclusion Criteria
  • Perioperative troponin elevation due to other factors than coronary artery disease such as proven pulmonary embolism or sepsis
  • Perioperative ST-elevation myocardial infarction (STEMI)
  • Perioperative symptomatic angina with troponin elevation
  • Patients with a history or ECG-signs of myocardial infarction
  • Patients with pre-existent heart failure, left ventricular dysfunction, significant valvular disease or left ventricle hypertrophy
  • Patients with significant valvular disease or left ventricle hypertrophy determined postoperatively with echocardiography.
  • Contra-indication for CMR such as claustrophobia or metal prosthesis
  • Allergic reaction to CT-contrast or gadolinium
  • Renal dysfunction with GFR < 50 ml/min, as determined after the operation
  • Unstable hemodynamics or other conditions disabling transport to the Radiology department
  • Expected major discomfort or substantial increase in pain sensation by undergoing CCTA or CMR
  • Admission at the ICU
  • Poor prognosis due to other medical conditions e.g. malignancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1. TnI elevationMinimal invasive cardiac imagingTnI 0.06-0.60ng/ml, no ischemia on ECG. Intervention: minimal invasive cardiac imaging
3. TnI elevationMinimal invasive cardiac imagingTnI\>6.00 ng/ml, no ischemia on ECG. Intervention: minimal invasive cardiac imaging
5. TnI elevationMinimal invasive cardiac imagingTnI \>6.00 ng/ml, ischemia on ECG and Hb\>5.0. Intervention: minimal invasive cardiac imaging
4. TnI elevationMinimal invasive cardiac imagingTnI \>6.00 ng/ml, ischemia on ECG and Hb\<5.1. Intervention: minimal invasive cardiac imaging
2. TnI elevationMinimal invasive cardiac imagingTnI 0.61-6.00 ng/ml, no ischemia on ECG. Intervention: minimal invasive cardiac imaging
ControlMinimal invasive cardiac imagingTnI \<0.06 ng/ml, no ischemia on ECG. Intervention: minimal invasive cardiac imaging
Primary Outcome Measures
NameTimeMethod
Coronary artery diseaseDuring hospital admission

Coronary artery disease with luminal narrowing \> 50 % in one or more major epicardial vessels by CCTA.

Secondary Outcome Measures
NameTimeMethod
Coronary calcium scoreDuring hospital admission

Agatston coronary calcium score

Extent of coronary artery atherosclerosisDuring hospital admission

Presence and extent of coronary artery atherosclerosis as measured with coronary CCTA

Minimal myocardial injuryDuring hospital admission

Minimal myocardial injury measured by late gadolinium enhancement on CMR.

Trial Locations

Locations (1)

UMC Utrecht

🇳🇱

Utrecht, Netherlands

© Copyright 2025. All Rights Reserved by MedPath